Cargando…

927. Clinical Characteristics and Outcomes of Norovirus Infection in Patients with Hematologic Malignancies: A Retrospective, Single Center Study

BACKGROUND: Norovirus (NV) gastroenteritis has been identified as a cause of significant morbidity among hematopoietic stem cell transplant (HSCT) recipients, often with associated complications. Current guidelines recommend symptomatic relief with antimotility agents, rehydration, and reduction in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brooks, Taylor, Crilley, Thomas A, Russell, Gregory B, Gaglani, Bhavita, Jakharia, Niyati
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644815/ http://dx.doi.org/10.1093/ofid/ofab466.1122

Ejemplares similares

P927: CLINICAL CHARACTERISTICS, SURVIVAL OUTCOMES AND PROGNOSIS IN 123 IMMUNOGLOBULIN D MULTIPLE MYELOMA PATIENTS: A RETROSPECTIVE SINGLE-CENTER
por: Liu, J., et al.
Publicado: (2022)

927. Antiretroviral Laboratory Monitoring and Implications for HIV Clinical Care in the Era of COVID-19 and Beyond
por: Fantry, Lori E, et al.
Publicado: (2020)

927 Laboratory
por: Jeanneret, Guillaume
Publicado: (2014)

440. Necrotizing Soft-Tissue Infections Involving Actinomyces Species
por: Jakharia, Niyati, et al.
Publicado: (2019)

1562. Impact of Skin Biopsy on Diagnosing Infections and Changing Treatment in Cancer Patients with New Skin Rash
por: Jakharia, Niyati, et al.
Publicado: (2018)

927 Rifampin for Surgically Treated Staphylococcal Infective Endocarditis
por: Shrestha, Nabin, et al.
Publicado: (2014)

New CCT Magnets in 927
por: Ordan, Julien Marius
Publicado: (2018)

927. Tap Water Avoidance Decreases Rates of Nontuberculous Mycobacteria in Intensive Care Units
por: Baker, Arthur W, et al.
Publicado: (2018)

P1543: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES THAT NEED VASOACTIVE SUPPORT – SINGLE CENTER STUDY
por: Vitkon, Roy, et al.
Publicado: (2023)

927. Successful Implementation of an Inpatient Fluoroquinolone (FQ) Pre-Authorization (PA) Program at a Tertiary Care Academic Center and Associated Changes in Antibiotic Use, Antibiogram Susceptibility, and Provider Behavioral Changes
por: Taylor, Lindsay, et al.
Publicado: (2022)

Outcomes of Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies
por: Chien, Kelly S., et al.
Publicado: (2022)

COVID-19 Infection in Children with Down Syndrome and Hematologic Malignancies
por: Foxworthy, Blake, et al.
Publicado: (2022)

208. Variation in Clinical Practice and Attitudes in the Management of Fever and Neutropenia in Patients With Hematologic Malignancy: A Survey of Cancer Centers Across the United States
por: Aitken, Samuel L, et al.
Publicado: (2020)

345. Acute Onset Diabetic Ketoacidosis/Hyperosmolar Hyperglycemic State in Patients Taking Integrase Strand Transfer Inhibitors
por: Ntem-Mensah, Afua Duker, et al.
Publicado: (2019)

700. Risk Factors and Molecular Epidemiology of Acute and Chronic Norovirus Infection at a Large Tertiary Care Cancer Center
por: Kondapi, Divya S, et al.
Publicado: (2021)

COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies
por: Martinez Lopez, Joaquin, et al.
Publicado: (2022)

Humoral Response to the Third-Dose COVID-19 Vaccination in Patients with Hematological Malignancy
por: Ikeda, Daisuke, et al.
Publicado: (2022)

Prediction of Mortality Following Cytokine Storm in Patients with Hematological Malignancies and COVID-19 Infections
por: Prakash, Rishab, et al.
Publicado: (2022)

927. Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation; A Medication Use and Safety Analysis
por: Nazareno, Ryan, et al.
Publicado: (2023)

532. COVID-19 Pneumonia in Patients with Hematologic Malignancies – A Report from the US Epicenter
por: Plate, Markus, et al.
Publicado: (2020)

755. Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies
por: Almutairy, Reem F, et al.
Publicado: (2020)

Retrospective study of the outcomes of patients admitted to the ICU with a hematological malignancy
por: Lewis, H, et al.
Publicado: (2012)

700. Ampicillin-Ceftriaxone Versus Ampicillin-Gentamicin for Definitive Therapy of Enterococcus faecalis Infective Endocarditis: A Propensity Score-Matched,Retrospective Cohort Analysis
por: Shah, Niyati H, et al.
Publicado: (2020)

1092. Increased Risk of Serious Infections in Mantle Cell Lymphoma Versus Other Hematologic Malignancies in Patients on Ibrutinib
por: Holowka, Thomas, et al.
Publicado: (2020)

305. Prevalence of Ceftriaxone Susceptible, Piperacillin-tazobactam Non-susceptible Escherichia coli Bacteremia in Patients with Hematologic Malignancy
por: Spitznogle, Sarah L, et al.
Publicado: (2020)

P1590: OUTCOME OF HYPERBARIC OXYGEN THERAPY IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES –A TERTIARY CANCER CENTER EXPERIENCE
por: Kim, K., et al.
Publicado: (2022)

Sepsis and neutropenia in hematological malignancies
por: Labiad, Y, et al.
Publicado: (2014)

CMV Infection in Hematopoietic Stem Cell Transplantation: Prevention and Treatment Strategies
por: Jakharia, Niyati, et al.
Publicado: (2021)

437. A Single-Center Experience of Solid versus Hematologic Malignancies in People Living with HIV
por: Daoud, Nour A, et al.
Publicado: (2022)

1077. Infectious complications after second allogeneic hematopoietic cell transplant (allo-HCT) in adult patients with hematological malignancies
por: Maurer, Stephen, et al.
Publicado: (2020)

710. Comparison of Initial CXR to CT in Patients (pts) with Hematologic Malignancy (HEM) and Documented Symptomatic Pulmonary Mucormycosis (PM)
por: Franklin, Alexander, et al.
Publicado: (2021)

P927: ACTUAL USAGE OF CURRENT SYSTEMIC TREATMENTS AND INFLUENCE OF KEY DRIVERS FOR MULTIPLE MYELOMA IN THE FIRST 2 LINES OF THERAPY. DATA FROM REAL-WORLD STUDY IN EU5 COUNTRIES.
por: Blin, Nicolas, et al.
Publicado: (2023)

1339. Impact of COVID-19 Pandemic on Activity of Other Respiratory Viral Pathogen and Norovirus
por: DiBiase, Lauren, et al.
Publicado: (2021)

632. Characterization of Cytomegalovirus (CMV) Reactivation in Patients with Malignant and Non-Malignant Hematological Diseases at large Academic Center in Saudi Arabia
por: AlQahtani, Hajar, et al.
Publicado: (2023)

348. Characteristics and Outcomes in Hospitalized Patients with Covid-19 Complicated by Fungemia: A Single Center Retrospective Study
por: Zahra, Aleena, et al.
Publicado: (2021)

751. Karius Cell-Free DNA Metagenomic Assay of Plasma Detects Pulmonary and Disseminated Trichosporon Infections in Patients with Hematological Malignancies
por: Chen, Tempe, et al.
Publicado: (2020)

1257. A phase II Prospective Randomized Study to Assess Ceftolozane-Tazobactam in the Management of Febrile Neutropenia in Patients with Hematological Malignancies
por: Chaftari, Anne-Marie, et al.
Publicado: (2020)

1598. Clinical implications of azole-resistant vs. azole-susceptible invasive aspergillosis in hematological malignancy (CLARITY) – a multicenter study
por: Seidel, Danila, et al.
Publicado: (2020)

1098. Norovirus Infection in Cancer Patients Undergoing Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T)
por: Kondapi, Divya S, et al.
Publicado: (2020)

2153. Impact of Norovirus Testing Changes on Hospital-Acquired Norovirus Infections
por: Fox, Josephine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3gseuhs0jjphrkivvkls76dcqt